| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-06 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.23 | 2e-05 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.12 | 6e-05 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.15 | 0.003 |